ArticleRSC advances2024
Enhanced fluorometric detection of histamine using red emissive amino acid-functionalized bimetallic nanoclusters.
Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lysine-capped gold nanoclusters doped with silver (LYS@Ag/Au NCs) have been developed for the sensitive and selective "turn-off" fluorescence detection of histamine. This fluorescent probe demonstrates excellent stability and a high quantum yield of 9.45%. Upon addition of histamine, a positively charged biogenic amine, to the LYS@Ag/Au NCs fluorescent probe, its fluorescence emission is quenched due to electrostatic interaction, aggregation, and hydrogen bond formation. The probe exhibits good sensitivity for the determination of histamine within the range of 0.003-350 μM, with a detection limit of 0.001 μM based on a signal-to-noise ratio of 3. Furthermore, the probe has been applied to detect biogenic amines in complicated matrices, highlighting its potential for practical applications. However, interference from the analogue histidine was observed during analysis, which can be mitigated by using a Supelclean™ LC-SAX solid-phase extraction column for removal.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.